Johannesburg's flagship academic hospital and Wits University's oncology hub, running South Africa's largest public radiation and medical oncology service and pioneering African cancer cohorts.
Charlotte Maxeke Johannesburg Academic Hospital, formerly the Johannesburg General Hospital, is the main tertiary hospital of the University of the Witwatersrand and hosts the largest public-sector oncology service in South Africa, with radiation oncology, medical oncology, haematology and bone marrow transplant, gynaecological and surgical oncology, and paediatric oncology. Wits research includes the Johannesburg Cancer Study, one of Africa's largest case-control studies of cancer risk factors and HIV, breast cancer outcomes in Black South African women, cervical cancer screening and HPV vaccination studies, Kaposi sarcoma and lymphoma in HIV, and the Wits Donald Gordon Medical Centre's transplant and hepatobiliary programmes. Wits also partners with the National Health Laboratory Service and the National Cancer Registry.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Johannesburg Hospital, including child institutions. 26 works · 118 citations · 77% open access · 8% clinical trials · 0% reviews.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Oesophageal cancer, Cervical cancer.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Oesophageal cancer, Cervical cancer.
Shares Cancer health disparities and equity, Global oncology and access in low- and middle-income countries, Cervical cancer, IMRT / IGRT (modern external beam).
Shares Cancer health disparities and equity, Global oncology and access in low- and middle-income countries, Oesophageal cancer, Cervical cancer.
Shares Cancer health disparities and equity, Global oncology and access in low- and middle-income countries, Cervical cancer, IMRT / IGRT (modern external beam).
Shares Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, HPV & HBV vaccination, Cervical cancer.
Shares Global oncology and access in low- and middle-income countries, HPV & HBV vaccination, Cervical cancer, IMRT / IGRT (modern external beam).
Shares Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, Diffuse large B-cell lymphoma, IMRT / IGRT (modern external beam).